focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 366.00
Bid: 366.00
Ask: 379.00
Change: 1.00 (0.27%)
Spread: 13.00 (3.552%)
Open: 356.00
High: 380.00
Low: 356.00
Prev. Close: 365.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Letter to icapital.biz Berhad

15 Sep 2016 09:46

RNS Number : 9378J
City of London Investment Group PLC
15 September 2016
 

CITY OF LONDON INVESTMENT GROUP PLC

 

TEXT OF LETTER TO ICAPITAL.BIZ BERHAD

 

(LONDON, 15 September, 2016) - City of London Investment Management has sent a letter (published in full below) to the board of icapital.biz Berhad (ICAP:MK) explaining its intention to oppose the re-election of directors at ICAP's forthcoming AGM.

 

Background

City of London Investment Group is an emerging markets fund manager which specialises in investing in closed-end investment companies. The firm is authorised and regulated by the Financial Conduct Authority and registered as an Investment Advisor with the Securities and Exchange Commission.

 

 

For further information, please contact:

 

Simon Westlake

City of London Investment Group

020 7711 1552

simon.westlake@citlon.co.uk 

 

 

Full text of letter

 

 

The Directors

icapital.biz Berhad

Unit 30-01, Level 30, Tower A

Vertical Business Suite

Avenue 3, Bangsar South

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Malaysia

 

 

15th September 2016

 

 

Dear Directors,

 

Twelfth Annual General Meeting of icapital.biz Berhad (ICAP)

 

Clients of City of London Investment Management Limited (CLIM) own 21,970,900 ICAP shares (15.7%). There has been no action in response to any of the points that were raised in our letter to you dated 26th August 2015, which set out our concerns regarding ICAP's poor performance and persistently wide discount to NAV. CLIM therefore confirms that it intends to continue voting against the re-election of incumbent directors. Accordingly, CLIM intends to vote against the re-election of Madam Leong So Seh at ICAP's 12th AGM on Saturday, 24th September 2016.

 

 

· Performance

We reiterate our call for performance comparisons in shareholder communications to be made on a total return basis, which is universally accepted in the investment industry as best practice.

 

The total return in the five years to end May 2016 for the FTSE Bursa Malaysia Index has been 23.1% cumulative (equivalent to 4.2% pa). In comparison ICAP's NAV return has been 13.0% cumulative (2.5% pa). The share price return over this period has been even worse due to discount widening, at 6.4% cumulative (1.3% pa). These performance figures have been sourced from Bloomberg.

 

The Chairman stated, in his letter to shareholders, dated 19th July 2016, that ICAP has 'performed beyond expectations'. We wish to make clear that ICAP's performance over the past five years has fallen significantly short of our own expectations.

 

· Cash Management

We note the continued extraordinarily high cash level, which has persisted at over 50% for 3 years and on which shareholders have been paying fees for fund management and investment research services. Cash at each calendar year end since ICAP was launched (31 December 2005 to 31 December 2015) has averaged 39%. ICAP is clearly operating with surplus cash which, in our opinion should be returned to shareholders.

 

· Expense Ratio

ICAP's expense ratio in 2016 was 1.9% (2015: 1.9%) which compares unfavourably with other country specific closed-end funds. The most significant item is the aggregate 1.5% incurred for fund management and investment research. CLIM urges the Board to negotiate competitive fees in order to reduce the expense ratio to an acceptable level.

 

· Discount Control

ICAP's prospectus dated 26 September 2005 explained clearly that the return for closed-end fund investors is a product of NAV performance and the discount movement. The Chairman's letter to Shareholders in the 2016 Annual Report refers to a 4% rise in ICAP's NAV for the 12 months ended 31 May 2016. However it does not mention that the share price actually declined over this period, because the discount widened. The discount averaged 22% in 2016 versus 20% in 2015 (source: Bloomberg). Neither the level nor the trend is acceptable and CLIM is disappointed that the Board has again failed to take any action to address this problem.

 

CLIM notes from the 2016 Annual Report the Board's deliberations on 27th July 2015 regarding share buy-backs and the accompanying statement that the "Fund's NAV could deteriorate if it uses its available fund to purchase own shares". Repurchasing shares at a discount to NAV will actually increase the NAV per share and in CLIM's opinion this would be a sensible use of ICAP's cash, particularly in view of the Manager's apparent shortage of investment ideas.

 

ICAP's prospectus included a section (6.7, page 64) on managing discounts, noting that the options available include 'share repurchase, open-ending, takeover, liquidation'. CLIM urges the Board to consider all these options and to formulate a strategy to reduce the discount from its present unacceptable level.

 

 

 

Yours sincerely,

 

Simon Westlake

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUGWBUPQURA
Date   Source Headline
17th Dec 20201:26 pmRNSDirector/PDMR Shareholding
14th Dec 20206:14 pmRNSDirector/PDMR Shareholding
24th Nov 20204:15 pmRNSHolding(s) in Company
19th Nov 20205:54 pmRNSHolding(s) in Company
11th Nov 20207:00 amRNSDividend cover template
30th Oct 20207:00 amRNSDirector/PDMR Shareholding
28th Oct 202011:12 amRNSDirector/PDMR Shareholding
28th Oct 202011:11 amRNSDirector/PDMR Shareholding
28th Oct 202011:09 amRNSDirector/PDMR Shareholding
19th Oct 20206:05 pmRNSResult of AGM
19th Oct 20206:05 pmRNSBoard Changes
13th Oct 202010:20 amEQSHardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion
9th Oct 20207:00 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSTrading Update 1st Quarter Funds under Management
5th Oct 20204:00 pmRNSHolding(s) in Company
2nd Oct 20204:54 pmRNSHolding(s) in Company
1st Oct 20204:48 pmRNSBoard Changes
1st Oct 20208:00 amRNSCompletion of all Share Merger
29th Sep 20207:00 amRNSProposed Share Issue
18th Sep 20203:13 pmRNSHolding(s) in Company
18th Sep 20202:04 pmRNSPublication of Supplementary Prospectus
17th Sep 20202:40 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
14th Sep 20207:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2020
14th Aug 20204:40 pmRNSSecond Price Monitoring Extn
14th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amEQSHardman & Co Research: City of London Investment Group (CLIG): Market recovery boosts FUM
14th Jul 20207:00 amRNSPRE-CLOSE TRADING UPDATE for year to 30 June 2020
14th Jul 20207:00 amRNSResult of General Meeting
30th Jun 20201:02 pmRNSDirector/PDMR Shareholding
19th Jun 20206:08 pmRNSDirector/PDMR Shareholding
15th Jun 20203:50 pmRNSHolding(s) in Company
12th Jun 20202:45 pmRNSPublication of Circular and Prospectus
9th Jun 20204:40 pmRNSSecond Price Monitoring Extn
9th Jun 20204:35 pmRNSPrice Monitoring Extension
9th Jun 20209:15 amEQSHardman & Co Research: City of London Investment Group (CLIG): Karpus transaction looks a winner
9th Jun 20207:00 amRNSProposed All Share Merger of CLIG with KMI
20th May 20206:17 pmRNSHolding(s) in Company
30th Apr 20204:40 pmRNSSecond Price Monitoring Extn
30th Apr 20204:36 pmRNSPrice Monitoring Extension
22nd Apr 20203:05 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Handling challenging markets well
22nd Apr 20202:38 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSFunds Under Management - Trading Update
30th Mar 20204:42 pmRNSSecond Price Monitoring Extn
30th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 20204:36 pmRNSPrice Monitoring Extension
2nd Mar 202012:03 pmRNSHolding(s) in Company
26th Feb 20204:20 pmRNSDirector/PDMR Shareholding
21st Feb 20203:33 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Interim results validate good first half performance
21st Feb 202011:40 amRNSDirector/PDMR Shareholding
17th Feb 20208:23 amRNSHalf-year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.